Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (131-140 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|April 28, 2018
Neoadjuvant PD-1 blockade in NSCLCDavid Killock
Nature Reviews. Clinical Oncology|August 2, 2018
Benefit of nanomedicine confirmed in sAMLDavid Killock
Nature Reviews. Clinical Oncology|September 14, 2016
Breast cancer: Genetic signature might spare 100,000 women annually from chemotherapyDavid Killock
Nature Reviews. Clinical Oncology|April 26, 2017
Immunotherapy: Reinvigorated T-cell numbers counterbalance tumour burdenDavid Killock
Nature Reviews. Clinical Oncology|June 21, 2017
Haematological cancer: Brentuximab vedotin - a new standard for cutaneous T-cell lymphomaDavid Killock
Nature Reviews. Clinical Oncology|February 11, 2015
Drug therapy: Can the mitochondrial adverse effects of antibiotics be exploited to target cancer metabolism?David Killock
Nature Reviews. Clinical Oncology|May 30, 2023
Newly diagnosed AML: quizartinib improves OSDavid Killock
Nature Reviews. Clinical Oncology|August 18, 2025
ASTER 70 suggests no clinical benefit from adjuvant chemotherapy in older patients with ER<sup>+</sup>HER2<sup>-</sup> breast cancerDavid Killock
Nature Reviews. Clinical Oncology|March 14, 2023
Recurrent nasopharyngeal carcinoma: hyperfractionation of IMRT improves outcomesDavid Killock
Nature Reviews. Clinical Oncology|February 10, 2023
Docetaxel-based CRT improves survival in cisplatin-ineligible patientsDavid Killock
Pageof 31

Showing results (131-140 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|April 28, 2018
Neoadjuvant PD-1 blockade in NSCLCDavid Killock
Nature Reviews. Clinical Oncology|August 2, 2018
Benefit of nanomedicine confirmed in sAMLDavid Killock
Nature Reviews. Clinical Oncology|September 14, 2016
Breast cancer: Genetic signature might spare 100,000 women annually from chemotherapyDavid Killock
Nature Reviews. Clinical Oncology|April 26, 2017
Immunotherapy: Reinvigorated T-cell numbers counterbalance tumour burdenDavid Killock
Nature Reviews. Clinical Oncology|June 21, 2017
Haematological cancer: Brentuximab vedotin - a new standard for cutaneous T-cell lymphomaDavid Killock
Nature Reviews. Clinical Oncology|February 11, 2015
Drug therapy: Can the mitochondrial adverse effects of antibiotics be exploited to target cancer metabolism?David Killock
Nature Reviews. Clinical Oncology|May 30, 2023
Newly diagnosed AML: quizartinib improves OSDavid Killock
Nature Reviews. Clinical Oncology|August 18, 2025
ASTER 70 suggests no clinical benefit from adjuvant chemotherapy in older patients with ER<sup>+</sup>HER2<sup>-</sup> breast cancerDavid Killock
Nature Reviews. Clinical Oncology|March 14, 2023
Recurrent nasopharyngeal carcinoma: hyperfractionation of IMRT improves outcomesDavid Killock
Nature Reviews. Clinical Oncology|February 10, 2023
Docetaxel-based CRT improves survival in cisplatin-ineligible patientsDavid Killock
Pageof 31